PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,443,092 | -43.6% | 64,395 | +2.3% | 0.18% | -48.3% |
| Q2 2023 | $2,558,834 | -16.1% | 62,917 | -0.1% | 0.35% | -14.8% |
| Q1 2023 | $3,049,976 | +27.0% | 62,964 | +0.1% | 0.41% | +6.2% |
| Q4 2022 | $2,400,702 | -32.2% | 62,895 | -10.9% | 0.39% | -27.4% |
| Q3 2022 | $3,543,000 | -8.9% | 70,579 | -27.3% | 0.54% | +56.3% |
| Q2 2022 | $3,887,000 | +10.9% | 97,031 | +3.3% | 0.34% | +13.6% |
| Q1 2022 | $3,506,000 | -63.2% | 93,969 | -66.2% | 0.30% | -43.3% |
| Q4 2018 | $9,528,000 | -27.0% | 277,609 | -0.0% | 0.53% | -1.7% |
| Q3 2018 | $13,048,000 | +39.4% | 277,621 | +0.0% | 0.54% | +52.7% |
| Q2 2018 | $9,363,000 | +24.6% | 277,601 | +0.0% | 0.36% | +39.8% |
| Q1 2018 | $7,512,000 | +327.3% | 277,600 | +72.3% | 0.25% | +120.9% |
| Q4 2016 | $1,758,000 | -24.5% | 161,100 | -3.0% | 0.12% | -15.4% |
| Q3 2016 | $2,327,000 | – | 166,100 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |